{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:55:15Z","timestamp":1783565715964,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clbc.2024.04.002","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T13:01:53Z","timestamp":1712408513000},"page":"e519-e527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7390-4428","authenticated-orcid":false,"given":"Matheus Wohlfahrt","family":"Baumgarten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuri Martin","family":"Goemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Selbach","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4186-5532","authenticated-orcid":false,"given":"Ana Luiza","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.clbc.2024.04.002_bib0001","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.002_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"10.1016\/j.clbc.2024.04.002_bib0003","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/1055-9965.EPI-18-0877","article-title":"A linkage between thyroid and breast cancer: a common etiology?","volume":"28","author":"Bolf","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.clbc.2024.04.002_bib0004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1158\/1055-9965.EPI-15-0833","article-title":"The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis","volume":"25","author":"Nielsen","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.002_bib0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1054\/bjoc.2000.1603","article-title":"Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England","volume":"84","author":"Evans","year":"2001","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2024.04.002_bib0006","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/jc.2007-1154","article-title":"The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer","volume":"93","author":"Brown","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.clbc.2024.04.002_bib0007","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1089\/thy.2007.0171","article-title":"Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis","volume":"17","author":"Subramanian","year":"2007","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.clbc.2024.04.002_bib0008","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1089\/thy.2014.0561","article-title":"A possible association between thyroid cancer and breast cancer","volume":"25","author":"An","year":"2015","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.clbc.2024.04.002_bib0009","first-page":"1067","article-title":"Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors \u03b1 and \u03b2","volume":"36","author":"Kumar","year":"2010","journal-title":"Int J Oncol"},{"issue":"22","key":"10.1016\/j.clbc.2024.04.002_bib0010","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1001\/archinte.159.22.2713","article-title":"Thyroid carcinomas after irradiation for a first cancer during childhood","volume":"159","author":"de Vathaire","year":"1999","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.clbc.2024.04.002_bib0011","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MED.0000000000000273","article-title":"The thyroid and breast cancer","volume":"23","author":"Smyth","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"10.1016\/j.clbc.2024.04.002_bib0012","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/bcr609","article-title":"Breast cancer in association with thyroid disorders","volume":"5","author":"Turken","year":"2003","journal-title":"Breast Cancer Res"},{"issue":"32","key":"10.1016\/j.clbc.2024.04.002_bib0013","doi-asserted-by":"crossref","first-page":"52450","DOI":"10.18632\/oncotarget.9547","article-title":"Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.002_bib0014","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4174\/astr.2014.86.4.169","article-title":"The prognosis and treatment of primary thyroid cancer occurred in breast cancer patients: comparison with ordinary thyroid cancer","volume":"86","author":"Park","year":"2014","journal-title":"Ann Surg Treat Res"},{"issue":"11","key":"10.1016\/j.clbc.2024.04.002_bib0015","doi-asserted-by":"crossref","first-page":"e0225986","DOI":"10.1371\/journal.pone.0225986","article-title":"Correction: Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer","volume":"14","author":"Cheng","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.clbc.2024.04.002_bib0016","unstructured":"Database S. Incidence\u2014SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, 2018 Sub (1975-2016 varying) - Linked To County Attributes - Total U.S., 1969-2017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released. Accessed 25 March 2020 at: https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2018\/."},{"key":"10.1016\/j.clbc.2024.04.002_bib0017","series-title":"SEER Summary Staging Manual - 2000: Codes and Coding Instructions","author":"Young","year":"2001"},{"key":"10.1016\/j.clbc.2024.04.002_bib0018","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"issue":"12","key":"10.1016\/j.clbc.2024.04.002_bib0019","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1002\/cam4.1856","article-title":"Association between breast cancer and thyroid cancer: a study based on 13 978 patients with breast cancer","volume":"7","author":"Huang","year":"2018","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.002_bib0020","first-page":"23","article-title":"Breast cancer in thyroid cancer survivors: an analysis of the Surveillance, Epidemiology, and End Results-9 database","volume":"159","author":"Kuo","year":"2016","journal-title":"Surg (United States)"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.002_bib0021","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3803\/jkes.2009.24.4.240","article-title":"Clinico-pathologic characteristics of the primary thyroid cancer in patients with breast cancer","volume":"24","author":"Shin","year":"2009","journal-title":"J Korean Endocr Soc"},{"issue":"5","key":"10.1016\/j.clbc.2024.04.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215948","article-title":"Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer","volume":"14","author":"Lei","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.002_bib0023","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00428-014-1539-0","article-title":"Molecular tests as prognostic factors in breast cancer","volume":"464","author":"Van De Vijver","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clbc.2024.04.002_bib0024","article-title":"Expression of estrogen and progesterone receptors in papillary thyroid carcinoma in Korea","author":"Young Ahn","year":"2021","journal-title":"Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.002_bib0025","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1089\/gtmb.2009.0068","article-title":"Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer","volume":"13","author":"Reba\u00ef","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"10.1016\/j.clbc.2024.04.002_bib0026","doi-asserted-by":"crossref","first-page":"e1149","DOI":"10.1016\/j.clbc.2018.04.009","article-title":"Inducing or preventing subsequent malignancies for breast cancer survivors? Double-edged sword of estrogen receptor and progesterone receptor","volume":"18","author":"Hu","year":"2018","journal-title":"Clin Breast Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:03:39Z","timestamp":1722074619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1526820924001022"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.04.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}